RTTNews | Dec 21, 2020 01:03AM EST

01:03 Monday, December 21, 2020 (RTTNews) - Astellas Pharma Says Phase 3 Trial Of XOSPATA Plus Azacitidine Did Not Meet Endpoint Of Overall Survival

For comments and feedback: contact editorial@rttnews.comCopyright(c) 2020 RTTNews.com. All Rights Reserved